These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2499166

  • 1. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors].
    Salinas Sánchez AS, Moreno Avilés J, Pérez Albacete M, Salmerón Lopez-Rua J, Guardiola Más A, Server Falgas G.
    Actas Urol Esp; 1989; 13(2):99-102. PubMed ID: 2499166
    [Abstract] [Full Text] [Related]

  • 2. Experiences on the local adriamycin treatment of bladder tumours.
    Somogyi L, Török A, Bors G, Frang D.
    Acta Chir Hung; 1987; 28(2):79-85. PubMed ID: 3618056
    [Abstract] [Full Text] [Related]

  • 3. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL, Ojea A, Jamardo D, Figueiredo L.
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract] [Full Text] [Related]

  • 5. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS, Jordan AM, Murphy WM.
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [Abstract] [Full Text] [Related]

  • 6. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A, Beyríe Tamayo W, Gozá León F, Muñoz YI.
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [Abstract] [Full Text] [Related]

  • 7. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 8. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA, de la Peña J, Hidalgo L, Cisneros J, Jiménez León J, Machuca J, Perdices C.
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract] [Full Text] [Related]

  • 9. [Prognostic factors in superficial bladder carcinoma. Analysis of 250 cases].
    Salinas Sánchez AS, Moreno Avilés J, García Hernández JA, Gómez Gómez GA, Martínez Pertusa P, Server Falgas G.
    Actas Urol Esp; 1989; 13(3):177-80. PubMed ID: 2763882
    [Abstract] [Full Text] [Related]

  • 10. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J, Bouffier B, Etievent JP, Bittard M.
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [Abstract] [Full Text] [Related]

  • 11. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF.
    Eur Urol; 1986; 12(4):253-6. PubMed ID: 3091370
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF.
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract] [Full Text] [Related]

  • 13. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Apr; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA, Mateo Cambón L, Casas Muiño RA, González Martín M.
    Actas Urol Esp; 1983 Apr; 7(4):269-74. PubMed ID: 6414263
    [No Abstract] [Full Text] [Related]

  • 15. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Apr; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravesical chemotherapy: how effective is it?
    Heney NM.
    Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J, Grof F.
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [Abstract] [Full Text] [Related]

  • 19. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1989 Jan; 13(1):41-3. PubMed ID: 2496584
    [Abstract] [Full Text] [Related]

  • 20. Early adjuvant adriamycin in superficial bladder carcinoma.
    Schulman CC, Denis LJ, Costerlinck W, De Sy W, Chantrie M, Bouffioux C, Van Cangh PJ, Van Erps P, De Sloover C.
    Prog Clin Biol Res; 1984 Jan; 162B():151-62. PubMed ID: 6390444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.